New Hampshire SB256 establishes safety and care requirements for clinician-administered drugs, ensuring they are dispensed appropriately in clinical.

New Hampshire SB256 amends RSA 420-B to include a new section on the dispensing of clinician-administered drugs. This bill defines "clinician-administered drug" as an outpatient prescription drug that cannot be self-administered and is typically given by a health care professional in clinical settings. It prohibits health maintenance organizations from refusing to authorize, approve, or pay for these drugs. Additionally, it mandates that unless a patient or prescriber requests otherwise, these drugs should not be dispensed directly to patients for transport to a healthcare facility.

New Hampshire SB256 establishes safety and care requirements for clinician-administered drugs, ensuring they are dispensed appropriately in clinical.

New Hampshire SB256 amends RSA 420-B to include a new section on the dispensing of clinician-administered drugs. This bill defines "clinician-administered drug" as an outpatient prescription drug that cannot be self-administered and is typically given by a health care professional in clinical settings. It prohibits health maintenance organizations from refusing to authorize, approve, or pay for these drugs. Additionally, it mandates that unless a patient or prescriber requests otherwise, these drugs should not be dispensed directly to patients for transport to a healthcare facility.